nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—Keratosis—Cyclosporine—focal segmental glomerulosclerosis	0.147	0.228	CcSEcCtD
Niacin—QPRT—kidney—focal segmental glomerulosclerosis	0.0535	0.257	CbGeAlD
Niacin—Sensation of heat—Cyclosporine—focal segmental glomerulosclerosis	0.0454	0.0705	CcSEcCtD
Niacin—NNMT—nephron tubule—focal segmental glomerulosclerosis	0.0287	0.138	CbGeAlD
Niacin—NNMT—kidney—focal segmental glomerulosclerosis	0.0252	0.121	CbGeAlD
Niacin—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.0246	0.0381	CcSEcCtD
Niacin—NNMT—cortex of kidney—focal segmental glomerulosclerosis	0.0246	0.118	CbGeAlD
Niacin—SLC16A3—kidney—focal segmental glomerulosclerosis	0.0172	0.0829	CbGeAlD
Niacin—SLC16A3—cortex of kidney—focal segmental glomerulosclerosis	0.0168	0.0807	CbGeAlD
Niacin—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.0145	0.0226	CcSEcCtD
Niacin—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0185	CcSEcCtD
Niacin—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0179	CcSEcCtD
Niacin—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0163	CcSEcCtD
Niacin—SLC16A1—kidney—focal segmental glomerulosclerosis	0.0105	0.0503	CbGeAlD
Niacin—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0157	CcSEcCtD
Niacin—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.0155	CcSEcCtD
Niacin—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00966	0.015	CcSEcCtD
Niacin—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00933	0.0145	CcSEcCtD
Niacin—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00925	0.0144	CcSEcCtD
Niacin—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.0091	0.0141	CcSEcCtD
Niacin—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00902	0.014	CcSEcCtD
Niacin—SLCO2B1—kidney—focal segmental glomerulosclerosis	0.00901	0.0433	CbGeAlD
Niacin—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00895	0.0139	CcSEcCtD
Niacin—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00874	0.0136	CcSEcCtD
Niacin—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00805	0.0125	CcSEcCtD
Niacin—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00794	0.0123	CcSEcCtD
Niacin—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00772	0.012	CcSEcCtD
Niacin—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00757	0.0118	CcSEcCtD
Niacin—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00752	0.0117	CcSEcCtD
Niacin—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00715	0.0111	CcSEcCtD
Niacin—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.0069	0.0107	CcSEcCtD
Niacin—SLC22A5—nephron tubule—focal segmental glomerulosclerosis	0.00681	0.0327	CbGeAlD
Niacin—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00667	0.0103	CcSEcCtD
Niacin—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.01	CcSEcCtD
Niacin—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00642	0.00996	CcSEcCtD
Niacin—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00635	0.00986	CcSEcCtD
Niacin—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00613	0.00951	CcSEcCtD
Niacin—SLC22A5—kidney—focal segmental glomerulosclerosis	0.00598	0.0288	CbGeAlD
Niacin—SLCO2B1—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.00586	0.0397	CbGpPWpGaD
Niacin—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00586	0.0091	CcSEcCtD
Niacin—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00583	0.00905	CcSEcCtD
Niacin—SLC22A5—cortex of kidney—focal segmental glomerulosclerosis	0.00583	0.028	CbGeAlD
Niacin—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00581	0.00901	CcSEcCtD
Niacin—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00567	0.00881	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—ANGPT2—focal segmental glomerulosclerosis	0.00562	0.0381	CbGpPWpGaD
Niacin—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00534	0.00828	CcSEcCtD
Niacin—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.00814	CcSEcCtD
Niacin—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00506	0.00785	CcSEcCtD
Niacin—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00502	0.00779	CcSEcCtD
Niacin—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00467	0.00725	CcSEcCtD
Niacin—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.00698	CcSEcCtD
Niacin—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.00689	CcSEcCtD
Niacin—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00441	0.00684	CcSEcCtD
Niacin—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.00658	CcSEcCtD
Niacin—HCAR2—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00386	0.0262	CbGpPWpGaD
Niacin—CYP2D6—kidney—focal segmental glomerulosclerosis	0.00386	0.0186	CbGeAlD
Niacin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.00594	CcSEcCtD
Niacin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.00594	CcSEcCtD
Niacin—HCAR3—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00366	0.0248	CbGpPWpGaD
Niacin—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00355	0.0055	CcSEcCtD
Niacin—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00354	0.00549	CcSEcCtD
Niacin—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00547	CcSEcCtD
Niacin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00547	CcSEcCtD
Niacin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00351	0.00545	CcSEcCtD
Niacin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00528	CcSEcCtD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.0034	0.023	CbGpPWpGaD
Niacin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.0051	CcSEcCtD
Niacin—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.00508	CcSEcCtD
Niacin—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00497	CcSEcCtD
Niacin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.00491	CcSEcCtD
Niacin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00489	CcSEcCtD
Niacin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.00484	CcSEcCtD
Niacin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00477	CcSEcCtD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00307	0.0208	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—ANGPT2—focal segmental glomerulosclerosis	0.00304	0.0206	CbGpPWpGaD
Niacin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.0047	CcSEcCtD
Niacin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.00468	CcSEcCtD
Niacin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.00463	CcSEcCtD
Niacin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00458	CcSEcCtD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00291	0.0197	CbGpPWpGaD
Niacin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00449	CcSEcCtD
Niacin—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00435	CcSEcCtD
Niacin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00428	CcSEcCtD
Niacin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00427	CcSEcCtD
Niacin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.00416	CcSEcCtD
Niacin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00406	CcSEcCtD
Niacin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00406	CcSEcCtD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00261	0.0177	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00403	CcSEcCtD
Niacin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.00397	CcSEcCtD
Niacin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00389	CcSEcCtD
Niacin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00389	CcSEcCtD
Niacin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00378	CcSEcCtD
Niacin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00376	CcSEcCtD
Niacin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.00371	CcSEcCtD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00236	0.016	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00234	0.0158	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00354	CcSEcCtD
Niacin—SLC16A3—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00228	0.0154	CbGpPWpGaD
Niacin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00352	CcSEcCtD
Niacin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00349	CcSEcCtD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00224	0.0152	CbGpPWpGaD
Niacin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00347	CcSEcCtD
Niacin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00346	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00222	0.015	CbGpPWpGaD
Niacin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00342	CcSEcCtD
Niacin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00338	CcSEcCtD
Niacin—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.00217	0.0147	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00336	CcSEcCtD
Niacin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.00333	CcSEcCtD
Niacin—HCAR2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00209	0.0142	CbGpPWpGaD
Niacin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00318	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—FN1—focal segmental glomerulosclerosis	0.002	0.0136	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.002	0.0136	CbGpPWpGaD
Niacin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00309	CcSEcCtD
Niacin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00307	CcSEcCtD
Niacin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00307	CcSEcCtD
Niacin—HCAR3—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00198	0.0134	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00194	0.0131	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.0019	0.0129	CbGpPWpGaD
Niacin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00287	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.0018	0.0122	CbGpPWpGaD
Niacin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00279	CcSEcCtD
Niacin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00275	CcSEcCtD
Niacin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00266	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.0017	0.0115	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00166	0.0113	CbGpPWpGaD
Niacin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00257	CcSEcCtD
Niacin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00247	CcSEcCtD
Niacin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00245	CcSEcCtD
Niacin—SLC5A8—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.00158	0.0107	CbGpPWpGaD
Niacin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00245	CcSEcCtD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00158	0.0107	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.00157	0.0107	CbGpPWpGaD
Niacin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00244	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00152	0.0103	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00152	0.0103	CbGpPWpGaD
Niacin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00231	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00145	0.00979	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00133	0.009	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00132	0.00895	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00127	0.00857	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00126	0.00854	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00125	0.00849	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00125	0.00846	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00123	0.00833	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00121	0.00818	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.0012	0.00813	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.0012	0.00813	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00118	0.00802	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00115	0.00777	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00114	0.00775	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00114	0.00771	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00111	0.00753	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00109	0.0074	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00109	0.00737	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—FN1—focal segmental glomerulosclerosis	0.00108	0.00733	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00105	0.00714	CbGpPWpGaD
Niacin—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00105	0.00711	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00102	0.00688	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00101	0.00684	CbGpPWpGaD
Niacin—QPRT—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00101	0.00681	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000969	0.00657	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000963	0.00653	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000956	0.00648	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000946	0.00641	CbGpPWpGaD
Niacin—NNMT—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000935	0.00633	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000923	0.00625	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000919	0.00623	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000913	0.00619	CbGpPWpGaD
Niacin—QPRT—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000885	0.006	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000875	0.00593	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000861	0.00584	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000823	0.00558	CbGpPWpGaD
Niacin—NNMT—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000823	0.00557	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000817	0.00553	CbGpPWpGaD
Niacin—QPRT—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000815	0.00553	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000799	0.00542	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000782	0.0053	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000768	0.00521	CbGpPWpGaD
Niacin—NNMT—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000758	0.00514	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000742	0.00502	CbGpPWpGaD
Niacin—QPRT—Disease—LPL—focal segmental glomerulosclerosis	0.000733	0.00496	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000715	0.00484	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000713	0.00483	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000709	0.0048	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000678	0.00459	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000676	0.00458	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000672	0.00455	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000649	0.0044	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000616	0.00417	CbGpPWpGaD
Niacin—QPRT—Metabolism—LPL—focal segmental glomerulosclerosis	0.000613	0.00416	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000596	0.00404	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00059	0.004	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000575	0.00389	CbGpPWpGaD
Niacin—QPRT—Disease—NOS2—focal segmental glomerulosclerosis	0.000572	0.00388	CbGpPWpGaD
Niacin—NNMT—Metabolism—LPL—focal segmental glomerulosclerosis	0.00057	0.00386	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000565	0.00383	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000545	0.00369	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000543	0.00368	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000537	0.00364	CbGpPWpGaD
Niacin—QPRT—Metabolism—AGT—focal segmental glomerulosclerosis	0.000525	0.00356	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000517	0.0035	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000511	0.00346	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000493	0.00334	CbGpPWpGaD
Niacin—NNMT—Metabolism—AGT—focal segmental glomerulosclerosis	0.000488	0.00331	CbGpPWpGaD
Niacin—QPRT—Disease—SERPINE1—focal segmental glomerulosclerosis	0.000482	0.00326	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000467	0.00316	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000462	0.00313	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000456	0.00309	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000452	0.00306	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000451	0.00306	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000448	0.00304	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000439	0.00298	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000438	0.00297	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000425	0.00288	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000425	0.00288	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000415	0.00281	CbGpPWpGaD
Niacin—QPRT—Metabolism—ALB—focal segmental glomerulosclerosis	0.000403	0.00273	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000403	0.00273	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000402	0.00272	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.00039	0.00265	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000384	0.0026	CbGpPWpGaD
Niacin—NNMT—Metabolism—ALB—focal segmental glomerulosclerosis	0.000374	0.00254	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00037	0.00251	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000364	0.00246	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000357	0.00242	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000354	0.0024	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000336	0.00228	CbGpPWpGaD
Niacin—QPRT—Disease—TGFB1—focal segmental glomerulosclerosis	0.000304	0.00206	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000295	0.002	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000293	0.00199	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00029	0.00196	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000285	0.00193	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00028	0.00189	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—LPL—focal segmental glomerulosclerosis	0.000279	0.00189	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000246	0.00167	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000244	0.00165	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000244	0.00165	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AGT—focal segmental glomerulosclerosis	0.000238	0.00161	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000237	0.00161	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000226	0.00153	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000217	0.00147	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000214	0.00145	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000211	0.00143	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.0002	0.00135	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000186	0.00126	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—focal segmental glomerulosclerosis	0.000183	0.00124	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000181	0.00123	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000176	0.0012	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000154	0.00104	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LPL—focal segmental glomerulosclerosis	0.00015	0.00102	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AGT—focal segmental glomerulosclerosis	0.000129	0.000872	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—focal segmental glomerulosclerosis	9.87e-05	0.000669	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	6.87e-05	0.000465	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	6.04e-05	0.00041	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.57e-05	0.000377	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	4.19e-05	0.000284	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	3.58e-05	0.000243	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	2.75e-05	0.000186	CbGpPWpGaD
Niacin—Salicylic acid—ALB—focal segmental glomerulosclerosis	2.09e-05	1	CrCbGaD
